• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

LMNX:US

17.1000 USD 0.6200 3.50%

As of 17:20:00 ET on 07/24/2014.

Snapshot for Luminex Corp (LMNX)

Open: 17.6000 Day's Range: 17.0400 - 17.7800 Volume: 238,712
Previous Close: 17.7200 52wk Range: 15.7400 - 24.1000 1-Yr Rtn: -26.95%

Stock Chart for LMNX

No chart data available.
  • LMNX:US 17.1000
  • 1D
  • 1M
  • 1Y
17.7200
Interactive LMNX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LMNX

Current P/E Ratio (ttm) 36.0738
Estimated P/E(12/2014) 28.9831
Relative P/E vs. SPX 1.9830
Earnings Per Share (USD) (ttm) 0.4740
Est. EPS (USD) (12/2014) 0.5900
Est. PEG Ratio 1.1147
Market Cap (M USD) 727.16
Shares Outstanding (M) 42.52
30 Day Average Volume 182,080
Price/Book (mrq) 2.5640
Price/Sale (ttm) 3.2248
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LMNX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LMNX

Luminex Corporation develops, manufactures and markets biological testing technologies with applications throughout the clinical diagnostic and life science industries. The Company's open-architecture technologies enable large numbers of biological tests (bioassays) to be conducted and analyzed quickly and accurately.

Patrick J Balthrop SrPresident/CEOHarriss T CurrieSenior VP:Finance/CFO
Jeremy K Bridge-CookSenior VP:Research & DevMichael F PintekSenior VP:Operations
More Company Profile & Key Executives for LMNX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil